Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Ohlsson, Bodil ^a   Ekblad, Eva ^b   Veress, Béla ^a   Montgomery, Agneta ^a   Janciauskiene, Sabina ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTISERUM; BUSERELIN; C REACTIVE PROTEIN; CD40 ANTIGEN; DOMPERIDONE; GONADORELIN; GONADORELIN ANTIBODY; GONADORELIN RECEPTOR; LAXATIVE; LOMUSTINE; METHOTREXATE; METOCLOPRAMIDE; METRONIDAZOLE; ONDANSETRON; PAPAVERINE; PROCHLORPERAZINE; PROTON PUMP INHIBITOR; TETRACYCLINE; VINBLASTINE; ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; DRUG DERIVATIVE;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADULT; AGED; ANIMAL CELL; ANOREXIA; ANTIBODY TITER; ARTICLE; BLOATING; CASE REPORT; CELL SURVIVAL; CELL VIABILITY; CONSTIPATION; CYTOSTASIS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DIVERTICULOSIS; DRUG WITHDRAWAL; DYSPEPSIA; DYSPHAGIA; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIONEURITIS; GASTRIC DYSMOTILITY; HARD FECES; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; MALE; MYENTERIC NEURON; MYENTERIC PLEXUS; NAUSEA; NERVE CELL; NERVE CELL NECROSIS; NEURITIS; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; STOMACH PARESIS; VOMITING; WEIGHT REDUCTION; ANIMAL; BIOPSY; BLOOD; CELL CULTURE; COLON; DRUG EFFECT; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; IMMUNOLOGY; INTESTINE INNERVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD40; AUTOANTIBODIES; BIOPSY; BUSERELIN; C-REACTIVE PROTEIN; CELL SURVIVAL; CELLS, CULTURED; COLON; ENTERIC NERVOUS SYSTEM; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MIDDLE AGED; NEURONS; RATS; YOUNG ADULT;

EID: 77952376633     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-48     Document Type: Article

References (25)

1. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996, 334:1106-1115. 10.1056/NEJM199604253341707, 8598871.
2. Wood JD. Neuropathy in the brain-in-gut. Eur J Gastroenterol Hepatol 2000, 12:597-600. 10.1097/00042737-200012060-00002, 10912473.
3. Vogel JD, West GA, Danese S, de la Motte C, Phillips MH, Strong SA, Willis J, Fiocchi C. CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology 2004, 126:63-80. 10.1053/j.gastro.2003.10.046, 14699489.
4. Mysliwiec J, Oklota M, Nikolajuk A, Waligorski D, Gorska M. Serum CD40/CD40L system in Graves'disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response. Immunol Invest 2007, 36:247-257. 10.1080/08820130601069715, 17558708.
5. Ohlsson B, Veress B, Janciauskiene S, Montgomery A, Haglund M, Wallmark A. Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies. Gastroenterology 2007, 132:45-51. 10.1053/j.gastro.2006.10.036, 17241858.
6. Khanna R, Browne RM, Heiner AD, Clench MH, Mathias JR. Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy. Am J Physiol 1992, 262:G185-G190.
7. Ducker TE, Boss JW, Altug SA, Mehrabian H, Dekeratry DR, Clench MH, Mathias JR. Luteinizing hormone and human chorionic gonadotropin fragment the migrating myoelectrical complex in rat small intestine. Neurogastroenterol Motil 1996, 8:95-100.
8. Mathias JR, Clench MH, Altug SA, Mehrabian H, Dekeratry DR, Clench MH, Mathias JR. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Dig Dis Sci 1994, 39:1155-1162. 10.1007/BF02093778, 8200247.
9. Mathias JR, Clench MH, Abell TL, Koch KL, Lehman G, Robinson M, Rothstein R, Snape WJ. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci 1998, 43:1347-1355. 10.1023/A:1018888631286, 9635630.
10. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999, 45:1143-1147.
11. Hanson M, Lilja B. Gastric emptying in smokers. Scand J Gastroenterol 1987, 22:1102-1104. 10.3109/00365528708991965, 3423735.
12. Wingate D, Hongo M, Kellow J, Lindberg G, Smout A. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002, 17(Suppl):S1-14. 10.1046/j.1440-1746.17.s1.7.x, 12000590.
13. Lin Z, Sandgren K, Ekblad E. Increased expression of vasoactive intestinal peptide in cultured myenteric neurons from rat small intestine. Autonomic Neuroscience 2003, 107:9-19. 10.1016/S1566-0702(03)00077-8, 12927222.
14. Sandgren K, Lin Z, Fex Svenningsen T, Ekblad E. Vasoactive intestinal peptide and nitric oxide promote survival of adult rat myenteric neurones in culture. J Neurosci Res 2003, 72:595-602. 10.1002/jnr.10612, 12749024.
15. Törnblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002, 123:1972-1979. 10.1053/gast.2002.37059, 12454854.
16. Takase H, Yamamura E, Murakami Y, Ikeuchi T, Osada Y. Gastrointestinal invasion by herpes simplex virus type 1 inoculated cutaneously into the immunosuppressed mice. Arch Virol 1994, 134:97-107. 10.1007/BF01379110, 8279963.
17. Mathias JR, Baskin GS, Reeves-Darby VG, Clench MH, Smith LL, Calhoon JH. Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate. Dig Dis Sci 1992, 37:1761-1768. 10.1007/BF01299872, 1330462.
18. El-Fawal HAN, Waterman SJ, De Feo A, Shamy MY. Neuroimmunotoxicology: Humoral assessment of neurotoxicity and autoimmune mechanisms. Environmental Health Perspectives 1999, 107:767-775. 10.2307/3434339, 1566239, 10502543.
19. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004, 16:515-531. 10.1111/j.1365-2982.2004.00538.x, 15500508.
20. Ho JS, Nagle GT, Mathias JR, Clench MH, Fan X, Kalmaz GD, Sallustio JE, Eaker EY. Presence of gonadotropin-releasing hormone (GnRH) receptor mRNA in rat myenteric plexus cells. Comp Biochem Physiol 1996, 113:817-821.
21. Huang W, Yao B, Sun L, Pu R, Wang L, Zhang R. Immunohistochemical and in situ hybridization studies of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract. Life Sci 2001, 68:1727-1734. 10.1016/S0024-3205(01)00968-7, 11270619.
22. Schally AV. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Peptides 1999, 20:1247-1262. 10.1016/S0196-9781(99)00130-8, 10573298.
23. Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003, 52:1435-41. 10.1136/gut.52.10.1435, 1773814, 12970136.
24. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 1978, 202:631-633. 10.1126/science.100883, 100883.
25. Nordin Fredriksson G, Schiopu A, Berglund G, Alm R, Shah PK, Nilsson J. Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events. Atherosclerosis 2007, 194:188-192.